22 September 2015 in The Journal of Laryngology & Otology
Objectives: To investigate the prevalence of allergic rhinitis among elementary and middle school students and examine its impact on their quality of life.Methods: Stratified sampling and cluster sampling surveys were performed among 10–17-year-old students in Changsha city from June 2011 to April 2012.Results: In the stratified sampling survey, the self-reported allergic rhinitis rate was 42.5 per cent. Further examination demonstrated that the average prevalence of allergic rhinitis was 19.4 per cent. The cluster sampling survey demonstrated that 214 of 814 students appeared to be atopic (26.3 per cent). The prevalence of allergic rhinitis and asthma was 17.2 and 2.1 per cent, respectively. In total, 71 atopic individuals (8.7 per cent) were without any symptoms of allergic disease. Further analysis showed that allergic rhinitis influenced the students' sleep, emotions and memory (p < 0.001).Conclusion: The prevalence of allergic rhinitis was 15.8 –19.4 per cent, showing an increase with age. Allergic rhinitis affected students' sleep, emotions and memory.
28 July 2025 in CNS Neuroscience & Therapeutics
Aims: The study aimed to investigate the role of NUS1 variants in Parkinson's disease (PD) progression and evaluate plasma Nogo‐B receptor (NgBR) as a potential biomarker.Methods: We recruited 228 PD patients, including 38 with NUS1 variants (NUS1‐PD) and 190 without (GU‐PD), and all underwent at least two follow‐up visits. Linear mixed‐effects models assessed motor and non‐motor symptom progression. Plasma NgBR levels were measured in PD, Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), and healthy controls (HC), and receiver operating characteristic curve analysis evaluated its diagnostic efficacy.Results: NUS1‐PD demonstrated an earlier age at onset and more severe motor features than GU‐PD at baseline. Longitudinal analyses showed similar progression rates of UPDRS III and H&Y stage (off‐medication) in NUS1‐PD and GU‐PD, but a slower progression rate of urinary function in NUS1‐PD (p = 0.024). Plasma NgBR levels were higher in PD than in HC, MSA, and PSP, with AUC values of 0.6832, 0.6716, and 0.6628, respectively. Plasma NgBR was associated with UPDRS III (p = 0.006) and cognitive impairment (p = 0.010).Conclusion: NUS1 variants show no impact on PD progression, while plasma NgBR may serve as a potential biomarker for PD diagnosis and clinical characteristics.